Complete Filing Data
KalVista Pharmaceuticals, Inc. reported Net Income Loss of -$183.44 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean KalVista Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$183.4M | -$126.6M | -$92.9M | -$82.3M | -$46.2M | -$29.1M | -$20.8M | -$15.8M | -$18.6M | -$11.4M | -$24.8M | -$13.4M | -$5.7M |
| Revenue * | $12.7M | $16.1M | $8.4M | $1.5M | $2.1M | ||||||||
| Operating Expenses | $188.0M | $140.4M | $110.9M | $96.6M | $57.9M | $53.2M | $45.9M | $27.1M | $23.8M | $17.3M | $21.1M | $11.7M | $5.6M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$2.5M | -$394.0K | -$604.0K | -$1.5M | $1.1M | $59.0K | -$1.3M | $1.5M | -$2.6M | -$2.2M | -$156.0K | ||
| Operating Income Loss | -$188.0M | -$140.4M | -$110.9M | -$96.6M | -$57.9M | -$40.5M | -$29.8M | -$18.7M | -$22.3M | -$15.2M | -$21.0M | -$11.7M | -$5.2M |
| Research And Development Expense | $71.7M | $86.2M | $80.3M | $70.2M | $41.3M | $40.2M | $35.0M | $18.2M | $12.7M | $14.7M | $16.2M | $8.3M | $4.2M |
| Other Nonoperating Income Expense | $4.8M | $9.8M | $15.6M | $14.7M | $9.9M | $9.8M | $7.7M | $4.4M | $2.3M | $2.0M | $550.0K | -$602.0K | -$59.0K |
| General And Administrative Expense | $116.3M | $54.3M | $30.6M | $26.4M | $16.6M | $13.0M | $10.9M | $8.9M | $11.2M | $2.7M | $4.9M | $3.4M | $1.4M |
| Nonoperating Income Expense | $7.9M | $13.8M | $18.0M | $14.3M | $11.7M | $11.3M | $9.1M | $2.9M | $3.7M | $3.7M | -$3.8M | -$1.7M | -$462.0K |
| Comprehensive Income Net Of Tax | -$185.2M | -$127.1M | -$92.1M | -$84.8M | -$45.8M | -$29.1M | -$21.6M | -$14.3M | -$21.2M | -$13.7M | -$7.4M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $2.4M | $1.3M | $1.3M | -$1.5M | -$473.0K | $285.0K | $440.0K | ||||||
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax | $1.6M | $1.3M | -$139.0K | -$581.0K | $153.0K | $300.0K | |||||||
| Other Comprehensive Income Loss Net Of Tax | -$1.7M | -$428.0K | $801.0K | -$2.4M | $450.0K | $44.0K | -$817.0K | ||||||
| Research And Development Tax Credits Receivable | $8.4M | $16.6M | $14.1M | $10.4M | $16.5M | $11.3M | $6.8M | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$180.1M | -$126.6M | -$92.9M | -$82.3M | -$82.3M | -$29.2M | -$20.7M | -$15.8M | -$18.6M | ||||
| License And Services Revenue | $29.0K | $29.0K | $415.0K | ||||||||||
| Income Tax Expense Benefit | $3.4M | $0.00 | $0.00 | $0.00 | $0.00 | -$124.0K | $124.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$49.5M | -$57.6M | -$51.8M | -$42.3M | -$39.1M | -$40.3M | -$43.1M | -$27.7M | -$25.3M | -$21.3M | -$22.3M | -$23.0M | -$22.5M | -$19.7M | -$16.1M | -$10.0M | -$10.4M | -$10.8M | -$6.6M | -$9.3M | -$5.9M | -$7.3M | -$8.5M | -$4.0M | -$3.3M | -$5.0M | -$657.0K | -$5.2M | -$5.0M | -$4.9M | -$4.2M | -$7.6M | -$3.3M | -$2.4M | -$7.4M | -$6.6M | -$5.7M | -$5.0M | -$9.0M | -$5.2M | -$4.7M | -$4.0M | -$2.6M | -$2.0M |
| Revenue * | $13.7M | $3.8M | $1.6M | $3.9M | $3.4M | $2.9M | $3.9M | $5.6M | $3.7M | $4.8M | $2.3M | $1.1M | $96.0K | $114.0K | $248.0K | $197.0K | $975.0K | |||||||||||||||||||||||||||
| Operating Expenses | $59.7M | $42.9M | $45.8M | $43.5M | $33.2M | $29.7M | $29.1M | $26.9M | $25.9M | $26.3M | $26.7M | $23.6M | $19.5M | $12.7M | $12.8M | $14.4M | $12.8M | $14.3M | $13.2M | $12.9M | $14.2M | $10.6M | $10.5M | $10.7M | $7.8M | $6.7M | $7.1M | $5.5M | $5.2M | $8.4M | $4.2M | $2.4M | $7.0M | $6.5M | $5.6M | $4.9M | $5.7M | $4.9M | $3.8M | $3.6M | $2.4M | $1.9M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $911.0K | -$3.0M | -$1.2M | $166.0K | $29.0K | -$27.0K | -$17.0K | -$419.0K | $91.0K | $1.1M | -$1.3M | -$403.0K | -$445.0K | -$33.0K | $49.0K | $813.0K | -$127.0K | $338.0K | $142.0K | $495.0K | -$89.0K | -$97.0K | $193.0K | -$1.3M | $2.4M | -$43.0K | $115.0K | $166.0K | $1.3M | $4.3M | -$3.6M | |||||||||||||
| Operating Income Loss | -$46.1M | -$42.9M | -$45.8M | -$43.5M | -$33.2M | -$29.7M | -$29.1M | -$26.9M | -$25.9M | -$26.3M | -$26.7M | -$23.6M | -$19.5M | -$12.7M | -$12.8M | -$14.4M | -$12.7M | -$9.3M | -$9.6M | -$6.7M | -$4.9M | -$7.0M | -$4.3M | -$5.9M | -$5.5M | -$8.1M | -$4.0M | -$2.4M | -$7.0M | -$6.5M | -$4.9M | -$5.7M | -$4.9M | -$3.6M | -$2.4M | -$1.9M | ||||||||
| Research And Development Expense | $12.0M | $12.6M | $16.6M | $18.7M | $22.5M | $19.1M | $19.3M | $20.1M | $18.1M | $18.2M | $19.7M | $17.5M | $13.7M | $9.1M | $9.1M | $11.2M | $11.2M | $9.8M | $9.7M | $7.7M | $7.9M | $8.4M | $4.5M | $4.4M | $3.5M | $3.3M | $2.9M | $332.0K | $947.0K | $3.5M | $3.5M | $4.5M | $3.9M | $2.1M | $1.8M | $1.4M | ||||||||
| Other Nonoperating Income Expense | $2.5M | $1.1M | $2.1M | $1.7M | $2.3M | $2.6M | $2.4M | $4.3M | $3.5M | $3.5M | $4.2M | $3.9M | $3.2M | $2.2M | $2.2M | $2.9M | $2.9M | $2.3M | $2.1M | $1.7M | $1.6M | $1.8M | $985.0K | $867.0K | $555.0K | $661.0K | $368.0K | $1.0K | -$3.0K | $1.0K | -$1.0K | $553.0K | -$71.0K | -$117.0K | ||||||||||
| General And Administrative Expense | $30.3M | $29.2M | $17.6M | $10.6M | $10.7M | $9.8M | $6.9M | $7.8M | $8.1M | $6.9M | $6.1M | $5.8M | $3.6M | $3.6M | $3.3M | $3.1M | $3.4M | $3.2M | $2.9M | $2.6M | $2.4M | $2.1M | $2.7M | $2.1M | $5.0M | $1.3M | $2.1M | $2.6M | $1.5M | $1.4M | $1.2M | $1.0M | $1.5M | $691.0K | $437.0K | |||||||||
| Nonoperating Income Expense | -$1.3M | -$1.3M | $3.5M | $4.4M | $4.1M | $2.1M | $3.8M | $5.6M | $3.6M | $3.3M | $4.2M | $4.0M | $3.4M | $2.6M | $2.4M | $3.6M | $3.4M | $3.4M | $2.2M | $2.7M | $1.6M | $2.0M | -$888.0K | $951.0K | $525.0K | $473.0K | $730.0K | $1.7M | $1.9M | -$3.3M | -$283.0K | -$199.0K | -$159.0K | |||||||||||
| Comprehensive Income Net Of Tax | -$49.2M | -$48.0M | -$42.1M | -$38.5M | -$28.9M | -$28.2M | -$25.1M | -$19.5M | -$23.4M | -$23.3M | -$23.1M | -$19.9M | -$16.2M | -$9.4M | -$10.8M | -$10.6M | -$9.2M | -$5.4M | -$7.4M | -$3.8M | -$3.1M | -$6.4M | -$2.8M | -$5.0M | -$4.8M | -$7.5M | -$2.0M | $885.0K | -$5.6M | |||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $187.0K | $286.0K | $263.0K | $651.0K | $1.2M | $582.0K | $192.0K | $440.0K | $392.0K | $658.0K | $52.0K | $98.0K | -$350.0K | -$295.0K | -$129.0K | -$48.0K | -$164.0K | -$5.0K | $40.0K | $28.0K | $28.0K | $232.0K | ||||||||||||||||||||||
| Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax | $771.0K | $724.0K | $256.0K | $649.0K | $557.0K | $293.0K | $133.0K | $595.0K | $314.0K | $1.0K | -$69.0K | -$16.0K | -$176.0K | -$97.0K | -$23.0K | $76.0K | $46.0K | $70.0K | $100.0K | |||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $327.0K | $493.0K | $168.0K | $627.0K | $171.0K | -$574.0K | $169.0K | $1.8M | -$1.2M | -$289.0K | -$619.0K | -$231.0K | -$57.0K | $689.0K | -$337.0K | $263.0K | $82.0K | $523.0K | -$61.0K | $135.0K | $193.0K | -$1.3M | $2.4M | -$43.0K | $115.0K | |||||||||||||||||||
| Research And Development Tax Credits Receivable | $1.3M | $1.4M | $7.5M | $11.4M | $9.9M | $23.0M | $20.0M | $19.1M | $11.9M | $20.0M | $17.2M | $11.3M | $17.4M | $13.6M | $7.6M | $14.7M | $12.6M | $14.8M | $11.8M | $12.6M | $9.0M | |||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$47.3M | -$44.3M | -$39.1M | -$29.0M | ||||||||||||||||||||||||||||||||||||||||
| License And Services Revenue | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $8.0K | $10.0K | $5.0K | $6.0K | |||||||||||||||||||||||||||||||||
| Income Tax Expense Benefit | $2.2M | $4.2M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $161.0M | $185.1M | $257.2M | $83.8M | $96.7M | $27.3M | $31.3M | -$37.1M | -$23.6M | -$44.2M | -$33.7M | -$28.3M | ||
| Cash And Cash Equivalents At Carrying Value | $31.8M | $56.2M | $30.7M | $50.6M | $15.8M | $32.0M | $31.0M | $21.8M | $2.5M | $481.0K | $9.8M | $8.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $56.2M | $30.7M | $50.6M | $15.8M | $32.0M | $51.1M | $31.0M | |||||||
| Retained Earnings Accumulated Deficit | -$469.7M | -$343.1M | -$250.2M | -$167.8M | -$121.6M | -$92.5M | -$71.7M | -$55.9M | -$37.3M | -$47.8M | ||||
| Prepaid Expense And Other Assets Current | $6.9M | $6.4M | $13.3M | $4.9M | $4.5M | $3.4M | $1.5M | $701.0K | $668.0K | $690.0K | ||||
| Liabilities Current | $22.8M | $15.0M | $11.6M | $9.8M | $7.7M | $18.1M | $23.2M | $3.0M | $3.2M | $7.1M | ||||
| Liabilities And Stockholders Equity | $235.4M | $183.2M | $203.9M | $272.0M | $92.5M | $118.1M | $61.4M | $34.3M | $24.7M | $6.6M | ||||
| Assets Current | $225.7M | $172.3M | $193.6M | $264.3M | $88.7M | $115.5M | $59.4M | $34.2M | $24.7M | $4.6M | ||||
| Assets | $235.4M | $183.2M | $203.9M | $272.0M | $92.5M | $118.1M | $61.4M | $34.3M | $24.7M | $6.6M | ||||
| Accounts Payable Current | $9.1M | $4.8M | $3.6M | $2.0M | $1.7M | $2.9M | $1.4M | $1.2M | $1.0M | $1.0M | ||||
| Property Plant And Equipment Net | $2.2M | $2.9M | $2.2M | $1.8M | $2.0M | $2.4M | $1.8M | $97.0K | $74.0K | $180.0K | ||||
| Common Stock Value | $42.0K | $34.0K | $25.0K | $24.0K | $18.0K | $17.0K | $11.0K | $10.0K | $1.0K | |||||
| Additional Paid In Capital Common Stock | $679.8M | $507.1M | $439.1M | $426.4M | $207.2M | $191.1M | $100.0M | $89.8M | $212.0K | $3.6M | ||||
| Accrued Liabilities Current | $12.4M | $9.1M | $7.0M | $6.9M | $5.5M | $5.6M | $3.1M | $1.9M | $2.1M | $1.6M | ||||
| Other Assets Noncurrent | $567.0K | $106.0K | $193.0K | $200.0K | $178.0K | $173.0K | $173.0K | $50.0K | $179.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.5M | -$3.1M | -$3.9M | -$1.4M | -$1.9M | -$1.9M | -$1.1M | -$2.6M | -$75.0K | |||||
| Amortization Of Debt Discount Premium | $14.0K | $92.0K | $988.0K | $2.6M | $685.0K | $193.0K | $780.0K | $384.0K | ||||||
| Liabilities Noncurrent | $6.0M | $7.1M | $7.2M | $5.0M | $1.1M | $3.3M | $10.9M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $100.5M | -$24.4M | $25.5M | -$19.9M | $34.8M | -$16.2M | -$19.0M | $20.1M | ||||||
| Available For Sale Securities Debt Securities Current | $178.6M | $93.1M | $135.5M | $198.3M | $51.9M | $68.8M | ||||||||
| Operating Lease Liability Noncurrent | $6.0M | $7.1M | $7.2M | $5.0M | $1.1M | |||||||||
| Operating Lease Liability Current | $1.3M | $1.1M | $977.0K | $863.0K | $588.0K | |||||||||
| Operating Lease Right Of Use Asset | $6.9M | $7.8M | $7.9M | $5.8M | $1.6M | |||||||||
| Non Cash Operating Lease Expense | $370.0K | -$12.0K | $84.0K | $179.0K | $114.0K | $13.0K | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$19.0M | $20.1M | $9.2M | $19.2M | $49.8M | -$5.9M | $1.5M | |||||||
| Marketable Securities Realized Gain Loss | -$139.0K | -$581.0K | $153.0K | $300.0K | $23.0K | |||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $725.0K | $162.0K | $1.2M | $3.2M | $4.8M | $309.0K | ||||||||
| Repayments Of Long Term Capital Lease Obligations | $54.0K | $209.0K | $151.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $17.0M | $59.4M | $116.8M | $164.4M | $148.5M | $180.9M | $217.6M | $97.9M | $139.3M | $184.4M | $143.8M | $164.6M | $207.9M | $227.5M | $244.4M | $58.6M | $65.0M | $74.4M | $89.7M | $97.8M | $101.9M | $104.0M | $107.0M | $26.3M | $28.6M | $31.1M | $26.7M | $34.8M | $33.9M | $36.0M | $43.1M | $49.3M | $54.6M | $59.3M | -$49.0M | ||||||
| Cash And Cash Equivalents At Carrying Value | $243.5M | $131.6M | $167.3M | $182.3M | $31.8M | $23.1M | $57.7M | $49.4M | $85.0M | $38.6M | $37.9M | $45.6M | $46.5M | $48.3M | $17.7M | $16.2M | $18.0M | $18.6M | $21.7M | $30.1M | $56.3M | $121.1M | $48.1M | $51.1M | $58.7M | $28.1M | $26.5M | $33.5M | $10.7M | $35.2M | $36.8M | $48.5M | $53.7M | $59.9M | $65.4M | $3.2M | $3.9M | $9.3M | $7.2M | $9.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $244.3M | $132.3M | $167.9M | $183.0M | $40.6M | $31.8M | $23.1M | $33.8M | $49.4M | $85.0M | $38.6M | $37.9M | $45.6M | $46.5M | $48.3M | $17.7M | $16.2M | $18.0M | $18.6M | $21.7M | $30.1M | $56.3M | $121.1M | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$739.1M | -$653.2M | -$600.9M | -$580.2M | -$510.2M | -$425.1M | -$396.0M | -$368.4M | -$316.8M | -$295.5M | -$273.2M | -$226.1M | -$203.6M | -$183.9M | -$152.9M | -$142.8M | -$132.4M | -$115.0M | -$115.0M | -$99.8M | -$84.0M | -$80.0M | -$76.7M | -$71.0M | -$65.8M | -$60.8M | -$51.7M | -$89.0M | -$86.6M | -$79.2M | -$72.6M | -$67.0M | -$62.0M | -$53.0M | |||||||
| Prepaid Expense And Other Assets Current | $8.5M | $19.7M | $6.7M | $6.2M | $7.5M | $5.5M | $5.5M | $7.5M | $8.6M | $8.9M | $11.1M | $8.4M | $7.3M | $5.5M | $4.6M | $1.5M | $3.3M | $3.6M | $2.6M | $2.7M | $3.9M | $1.9M | $1.5M | $2.0M | $1.4M | $841.0K | $1.2M | $605.0K | $1.1M | $1.0M | $1.2M | $1.6M | $1.6M | $1.1M | |||||||
| Liabilities Current | $45.1M | $45.2M | $25.6M | $26.1M | $22.4M | $19.1M | $17.8M | $14.1M | $11.6M | $11.3M | $9.7M | $9.6M | $10.1M | $8.2M | $6.5M | $9.5M | $8.5M | $9.8M | $10.5M | $14.0M | $18.8M | $20.9M | $22.9M | $24.1M | $3.5M | $3.8M | $3.2M | $1.9M | $1.9M | $3.9M | $4.3M | $3.8M | $4.2M | $11.0M | |||||||
| Liabilities And Stockholders Equity | $339.9M | $250.8M | $276.0M | $294.8M | $200.2M | $114.0M | $138.7M | $160.3M | $203.5M | $162.8M | $182.3M | $225.1M | $243.8M | $259.1M | $66.2M | $75.4M | $83.9M | $102.9M | $112.1M | $119.9M | $126.5M | $132.6M | $57.6M | $66.7M | $34.7M | $30.8M | $38.1M | $35.9M | $38.0M | $49.7M | $56.8M | $62.1M | $67.6M | $7.7M | |||||||
| Assets Current | $325.2M | $241.7M | $267.4M | $286.0M | $191.6M | $104.1M | $128.6M | $149.8M | $192.1M | $151.2M | $170.4M | $214.5M | $234.5M | $249.8M | $62.5M | $72.1M | $80.2M | $99.0M | $107.9M | $115.7M | $124.1M | $130.1M | $55.2M | $65.7M | $34.1M | $30.2M | $38.0M | $35.8M | $38.0M | $49.5M | $54.9M | $61.4M | $67.0M | $4.3M | |||||||
| Assets | $339.9M | $250.8M | $276.0M | $294.8M | $200.2M | $114.0M | $138.7M | $160.3M | $203.5M | $162.8M | $182.3M | $225.1M | $243.8M | $259.1M | $66.2M | $75.4M | $83.9M | $102.9M | $112.1M | $119.9M | $126.5M | $132.6M | $57.6M | $66.7M | $34.7M | $30.8M | $38.1M | $35.9M | $38.0M | $49.7M | $56.8M | $62.1M | $67.6M | $7.7M | |||||||
| Accounts Payable Current | $8.1M | $4.9M | $5.9M | $5.7M | $10.8M | $3.1M | $4.9M | $5.1M | $1.7M | $3.4M | $2.9M | $2.2M | $3.2M | $1.4M | $641.0K | $2.2M | $1.8M | $3.0M | $2.2M | $3.1M | $3.0M | $3.0M | $2.3M | $1.6M | $1.0M | $1.9M | $755.0K | $431.0K | $187.0K | $793.0K | $1.5M | $1.5M | $2.0M | $2.5M | |||||||
| Property Plant And Equipment Net | $3.2M | $2.0M | $1.8M | $1.9M | $2.1M | $2.4M | $2.5M | $2.8M | $3.0M | $3.1M | $3.0M | $2.2M | $2.2M | $1.9M | $1.9M | $1.9M | $2.0M | $2.3M | $2.4M | $2.3M | $2.3M | $2.3M | $2.3M | $774.0K | $602.0K | $592.0K | $97.0K | $160.0K | $805.0K | $362.0K | $374.0K | $329.0K | |||||||||
| Common Stock Value | $50.0K | $50.0K | $49.0K | $49.0K | $43.0K | $34.0K | $34.0K | $34.0K | $34.0K | $25.0K | $25.0K | $24.0K | $24.0K | $24.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $11.0K | $11.0K | $11.0K | $10.0K | $10.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $1.0K | |||||||
| Additional Paid In Capital Common Stock | $762.8M | $753.7M | $748.2M | $746.9M | $685.8M | $516.9M | $513.9M | $510.6M | $504.7M | $444.6M | $441.9M | $436.3M | $432.8M | $429.8M | $212.7M | $209.8M | $208.4M | $206.1M | $205.0M | $203.7M | $190.1M | $189.2M | $105.4M | $99.7M | $99.4M | $90.0M | $89.4M | $122.9M | $122.6M | $122.3M | $121.9M | $121.6M | $121.3M | ||||||||
| Accrued Liabilities Current | $20.8M | $27.3M | $18.3M | $18.9M | $10.4M | $14.8M | $11.7M | $8.0M | $8.9M | $6.9M | $5.8M | $6.5M | $6.0M | $5.9M | $5.3M | $6.9M | $6.2M | $4.9M | $5.0M | $4.3M | $3.4M | $3.0M | $3.1M | $2.3M | $2.3M | $1.7M | $2.4M | $1.4M | $1.7M | $1.1M | $1.3M | $1.3M | $1.7M | $1.8M | |||||||
| Other Assets Noncurrent | $2.4M | $1.5M | $1.4M | $1.4M | $605.0K | $397.0K | $337.0K | $106.0K | $197.0K | $197.0K | $218.0K | $193.0K | $193.0K | $200.0K | $181.0K | $178.0K | $178.0K | $173.0K | $173.0K | $173.0K | $173.0K | $173.0K | $173.0K | $173.0K | $991.0K | $218.0K | $179.0K | $179.0K | |||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$6.7M | -$5.2M | -$2.2M | -$2.4M | -$2.9M | -$3.3M | -$3.5M | -$2.9M | -$3.5M | -$5.3M | -$4.2M | -$2.3M | -$1.7M | -$1.5M | -$1.3M | -$2.0M | -$1.6M | -$1.4M | -$1.5M | -$2.0M | -$2.1M | -$2.2M | -$2.4M | -$136.0K | -$2.6M | -$2.5M | -$2.9M | ||||||||||||||
| Amortization Of Debt Discount Premium | -$7.0K | $5.0K | $62.0K | $391.0K | $753.0K | $68.0K | $35.0K | $7.0K | $707.0K | $48.0K | |||||||||||||||||||||||||||||||
| Liabilities Noncurrent | $136.3M | $110.2M | $105.3M | $4.7M | $5.0M | $6.3M | $6.5M | $6.9M | $7.4M | $7.7M | $8.0M | $7.5M | $6.2M | $6.5M | $1.1M | $932.0K | $1.0M | $3.4M | $3.8M | $4.1M | $3.7M | $4.7M | $8.5M | $14.0M | $149.0K | $213.0K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.3M | $59.0K | -$6.8M | $7.1M | -$2.2M | $2.2M | -$1.9M | ||||||||||||||||||||||||||||||||||
| Available For Sale Securities Debt Securities Current | $65.7M | $89.0M | $85.9M | $86.0M | $142.4M | $52.5M | $45.5M | $73.8M | $86.6M | $83.7M | $104.2M | $149.2M | $163.3M | $182.3M | $32.6M | $39.7M | $46.3M | $62.0M | $71.7M | $70.3M | $54.8M | ||||||||||||||||||||
| Operating Lease Liability Noncurrent | $9.1M | $4.3M | $4.3M | $4.4M | $5.0M | $6.3M | $6.5M | $6.9M | $7.4M | $7.7M | $8.0M | $7.5M | $6.2M | $6.5M | $1.1M | $932.0K | $1.0M | $926.0K | $1.1M | $1.2M | |||||||||||||||||||||
| Operating Lease Liability Current | $1.4M | $2.0M | $1.4M | $1.5M | $1.3M | $1.2M | $1.1M | $1.1M | $1.1M | $1.0M | $997.0K | $1.0M | $930.0K | $905.0K | $592.0K | $422.0K | $513.0K | $592.0K | $602.0K | $580.0K | |||||||||||||||||||||
| Operating Lease Right Of Use Asset | $9.1M | $5.5M | $5.4M | $5.6M | $5.9M | $7.0M | $7.3M | $7.6M | $8.1M | $8.4M | $8.7M | $8.2M | $7.0M | $7.2M | $1.7M | $1.3M | $1.5M | $1.5M | $1.6M | $1.7M | |||||||||||||||||||||
| Non Cash Operating Lease Expense | -$5.0K | $6.0K | $23.0K | $22.0K | $8.0K | $1.0K | |||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.9M | -$3.0M | -$4.5M | -$6.1M | -$5.3M | -$716.0K | -$505.0K | ||||||||||||||||||||||||||||||||||
| Marketable Securities Realized Gain Loss | $314.0K | -$16.0K | -$23.0K | $70.0K | $29.0K | ||||||||||||||||||||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $725.0K | $1.2M | |||||||||||||||||||||||||||||||||||||||
| Repayments Of Long Term Capital Lease Obligations | $54.0K | $52.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $12.3M | $21.9M | $9.9M | $11.1M | $7.1M | $4.4M | $3.0M | $1.1M | $394.0K | $118.0K | $785.0K | $381.0K | $238.0K |
| Financing Cash Flow * | $159.7M | $150.7M | $58.1M | $1.6M | $212.1M | $11.6M | $87.9M | $9.0M | $2.0K | $33.0M | $72.1M | $5.5M | $6.4M |
| Investing Cash Flow * | $91.0M | -$84.7M | $41.4M | $57.9M | -$147.7M | $16.8M | -$69.4M | -$1.4M | $34.1M | -$11.0K | -$1.4M | -$159.0K | -$18.0K |
| Operating Cash Flow * | -$152.9M | -$89.2M | -$75.3M | -$78.1M | -$30.2M | -$44.8M | -$36.4M | $10.6M | -$23.7M | -$13.2M | -$20.9M | -$11.3M | -$4.9M |
| Payments To Acquire Property Plant And Equipment | $434.0K | $42.0K | $1.2M | $931.0K | $82.0K | $220.0K | $1.1M | $1.4M | $74.0K | $11.0K | $659.0K | $159.0K | $18.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.4M | $538.0K | -$6.7M | $9.3M | $244.0K | $1.1M | $2.0M | $746.0K | $81.0K | $475.0K | $532.0K | $561.0K | $46.0K |
| Increase Decrease In Accounts Payable | -$5.0M | $4.3M | $1.1M | $1.7M | $150.0K | -$1.0M | $1.5M | $217.0K | -$1.6M | $374.0K | $355.0K | $487.0K | $315.0K |
| Depreciation Depletion And Amortization | $941.0K | $816.0K | $718.0K | $564.0K | $537.0K | $512.0K | $378.0K | $180.0K | $40.0K | $33.0K | $133.0K | $54.0K | $27.0K |
| Increase Decrease In Accrued Liabilities | $14.4M | $3.2M | $1.9M | $472.0K | $983.0K | -$48.0K | $2.7M | $1.1M | -$1.9M | $1.2M | -$298.0K | $830.0K | $185.0K |
| Increase Decrease In Research And Development Tax Credit Receivable | -$7.3M | -$8.2M | $2.3M | $5.2M | -$7.5M | $5.8M | $4.9M | $4.3M | $600.0K | $1.1M | $94.0K | ||
| Proceeds From Issuance Of Common Stock | $55.9M | $96.9M | $56.6M | $210.6M | $11.4M | $87.9M | $9.1M | $2.0K | $1.0K | $67.9M | -$1.2M | ||
| Payments To Acquire Available For Sale Securities Debt | $30.6M | $189.2M | $98.2M | $136.9M | $201.2M | $49.8M | $79.9M | ||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $122.5M | $105.0M | $140.9M | $195.7M | $53.6M | $66.8M | $11.5M | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.6M | -$1.2M | $1.2M | -$1.2M | $511.0K | $262.0K | -$1.2M | $2.0M | |||||
| Proceeds From Stock Plans | $5.8M | $646.0K | $449.0K | $1.6M | $1.5M | $216.0K | $242.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $5.4M | $3.0M | $3.3M | $2.6M | $2.8M | $1.2M | $1.1M | $347.0K | $221.0K | $282.0K | $312.0K | $368.0K | $289.0K | $37.0K | $118.0K | $100.0K | $50.0K | $59.0K |
| Financing Cash Flow * | $23.2M | $3.0M | $204.0K | $168.0K | $608.0K | $46.0K | $11.4M | $4.9M | $3.5M | $1.3M | ||||||||
| Investing Cash Flow * | $21.3M | $37.2M | $19.6M | $30.0M | $14.9M | $5.5M | -$1.5M | -$565.0K | -$110.0K | -$43.0K | -$184.0K | -$180.0K | -$1.0K | |||||
| Operating Cash Flow * | -$54.5M | -$40.2M | -$26.7M | -$22.7M | -$17.7M | -$3.6M | -$11.3M | -$6.2M | -$4.4M | -$5.7M | -$5.1M | -$4.0M | -$1.8M | |||||
| Payments To Acquire Property Plant And Equipment | $290.0K | $21.0K | $6.0K | $920.0K | $287.0K | $22.0K | $98.0K | $565.0K | $110.0K | $43.0K | $184.0K | $180.0K | $1.0K | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.6M | $783.0K | $1.0M | -$1.9M | $625.0K | -$1.3M | -$561.0K | $69.0K | $85.0K | $86.0K | -$85.0K | $437.0K | $68.0K | |||||
| Increase Decrease In Accounts Payable | $2.5M | $1.5M | $108.0K | -$678.0K | -$528.0K | $35.0K | $392.0K | $1.1M | $771.0K | $996.0K | -$272.0K | $1.0M | $24.0K | |||||
| Depreciation Depletion And Amortization | $252.0K | $224.0K | $193.0K | $158.0K | $132.0K | $128.0K | $121.0K | $50.0K | $32.0K | $8.0K | $34.0K | $31.0K | $10.0K | |||||
| Increase Decrease In Accrued Liabilities | -$8.2M | -$1.8M | -$1.2M | -$1.0M | -$1.0M | $538.0K | -$1.1M | $157.0K | -$185.0K | -$746.0K | -$246.0K | $146.0K | $118.0K | |||||
| Increase Decrease In Research And Development Tax Credit Receivable | -$826.0K | $1.3M | $2.1M | $3.6M | $3.2M | -$4.5M | $2.1M | -$919.0K | $530.0K | $275.0K | ||||||||
| Proceeds From Issuance Of Common Stock | $11.4M | $14.5M | $120.0K | |||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $20.0M | $983.0K | $25.8M | $10.1M | $19.0M | $9.8M | $19.6M | |||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $41.7M | $38.2M | $45.4M | $41.1M | $34.2M | $15.3M | $18.2M | |||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.7M | $117.0K | $84.0K | -$339.0K | -$3.0K | $254.0K | -$494.0K | |||||||||||
| Proceeds From Stock Plans | $595.0K | $3.0M | $204.0K | $168.0K | $608.0K | $46.0K | $32.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.69 | -$3.44 | -$3.33 | -$3.36 | -$2.42 | -$1.64 | -$1.38 | -$1.53 | -$4.47 | -$26.17 | -$1.30 | -$21.81 | -$13.42 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 45.0M | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 19.1M | 17.7M | 15.1M | 10.3M | 4.6M | 591.3K | 19.1M | 612.5K | 423.1K | ||||
| Common Stock Shares Outstanding | 42.5M | 34.2M | 24.6M | 24.4M | 17.8M | 17.3M | 10.8M | 9.7M | 0.00 | 691.3K | |||
| Common Stock Shares Issued | 42.5M | 34.2M | 24.6M | 24.4M | 17.8M | 17.3M | 10.8M | 9.7M | 0.00 | 691.3K | |||
| Weighted Average Number Of Shares Outstanding Basic | 49.7M | 36.8M | 27.9M | 24.5M | 19.1M | 17.7M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 49.7M | 36.8M | 27.9M | 24.5M | 19.1M | 17.7M | |||||||
| Earnings Per Share Basic | $-3.69 | $-3.44 | $-3.33 | $-3.36 | $-2.42 | $-1.64 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.92 | -$0.92 | -$0.91 | -$0.84 | -$0.84 | -$0.80 | -$0.74 | -$0.75 | -$0.90 | -$0.94 | -$0.92 | -$0.80 | -$0.66 | -$0.56 | -$0.58 | -$0.61 | -$0.37 | -$0.52 | -$0.33 | -$0.42 | -$0.49 | -$0.23 | -$0.22 | -$0.47 | -$0.06 | -$0.49 | -$0.50 | -$0.51 | -$0.43 | -$1.03 | -$5.98 | -$0.09 | -$0.28 | -$0.25 | -$0.21 | -$0.19 | -$0.40 | -$7.38 | -$6.82 | -$5.89 | -$4.26 | -$4.39 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 24.5M | 24.4M | 24.4M | 18.0M | 17.9M | 17.8M | 17.8M | 17.8M | 17.5M | 17.2M | 15.1M | 10.8M | 10.8M | 10.0M | 9.7M | 7.7M | 709.5K | 26.3M | 26.3M | 26.3M | 26.3M | 22.6M | 702.0K | 678.2K | 618.5K | 459.3K | |||||||||||||||||
| Common Stock Shares Outstanding | 50.5M | 49.8M | 49.5M | 49.4M | 43.1M | 34.6M | 34.4M | 34.3M | 34.1M | 24.6M | 24.6M | 24.5M | 24.4M | 24.4M | 18.0M | 17.9M | 17.9M | 17.8M | 17.8M | 17.8M | 17.2M | 17.2M | 10.8M | 10.8M | 10.8M | 9.7M | 9.7M | 26.3M | 26.3M | 26.3M | 26.3M | 26.3M | 26.3M | 708.5K | |||||||||
| Common Stock Shares Issued | 50.5M | 49.8M | 49.5M | 49.4M | 43.1M | 34.6M | 34.4M | 34.3M | 34.1M | 24.6M | 24.6M | 24.5M | 24.4M | 24.4M | 18.0M | 17.9M | 17.9M | 17.8M | 17.8M | 17.8M | 17.2M | 17.2M | 10.8M | 10.8M | 10.8M | 9.7M | 9.7M | 26.3M | 26.3M | 26.3M | 26.3M | 26.3M | 26.3M | 708.5K | |||||||||
| Weighted Average Number Of Shares Outstanding Basic | 53.9M | 52.6M | 46.7M | 46.6M | 34.7M | 34.6M | 34.4M | 28.3M | 24.6M | 24.6M | 24.5M | 24.4M | 24.4M | ||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 53.9M | 52.6M | 46.7M | 46.6M | 34.7M | 34.6M | 34.4M | 28.3M | 24.6M | 24.6M | 24.5M | 24.4M | 24.4M | ||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.92 | $-0.92 | $-0.91 | $-0.84 | $-0.84 | $-0.80 | $-0.74 | $-0.75 | $-0.90 | $-0.94 | $-0.92 | $-0.80 | $-0.66 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $6.4M | $3.9M | $2.2M | $1.1M | $903.0K | $1.8M | $1.4M | $82.0K | $36.0K | $50.0K | $5.0K | $2.0K | $2.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.3M | $21.9M | $9.9M | $11.1M | $7.1M | $4.4M | $3.0M | $1.1M | $394.0K | $118.0K | $785.0K | $381.0K | $238.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $2.5M | $138.0K | $90.0K | -$1.5M | -$847.0K | -$367.0K | $49.0K | -$1.6M | $1.4M | $1.7M | |||
| Foreign Currency Transaction Gain Loss Realized | $4.2M | -$760.0K | $1.6M | -$1.6M | $574.0K | -$74.0K | $80.0K | $651.0K | $1.4M | $1.7M | |||
| Stock Issued During Period Value Employee Benefit Plan | $449.0K | $1.6M | $1.5M | $216.0K | |||||||||
| Stock Issued During Period Value New Issues | $55.9M | $96.9M | $56.6M | $208.9M | $11.4M | $87.9M | $9.1M | $2.0K | $1.0K | $66.3M | |||
| Stock Issued During Period Value Stock Options Exercised | $4.9M | $184.0K | $216.0K | $242.0K | $36.0K | $155.0K | $229.0K | $17.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q3 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $1.9M | $1.4M | $1.4M | $1.6M | $684.0K | $776.0K | $923.0K | $732.0K | $449.0K | $242.0K | $258.0K | $290.0K | $274.0K | $137.0K | $193.0K | $259.0K | $372.0K | $505.0K | $590.0K | $723.0K | $204.0K | $89.0K | $14.0K | $1.0K | $2.0K | $7.0K | $10.0K | $19.0K | $20.0K | $12.0K | $2.0K | $2.0K | $1.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.4M | $3.6M | $3.2M | $3.0M | $3.2M | $3.1M | $12.4M | $3.2M | $3.3M | $2.3M | $2.5M | $2.6M | $2.8M | $2.9M | $2.8M | $1.2M | $1.2M | $1.2M | $1.1M | $1.2M | $1.1M | $797.0K | $976.0K | $347.0K | $285.0K | $273.0K | $221.0K | ||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$884.0K | -$983.0K | $67.0K | $1.1M | $1.1M | -$1.3M | $456.0K | $597.0K | -$317.0K | -$517.0K | -$198.0K | -$280.0K | -$51.0K | $301.0K | -$24.0K | $438.0K | $138.0K | $560.0K | -$453.0K | $248.0K | -$231.0K | $67.0K | -$1.9M | $83.0K | -$32.0K | -$195.0K | $352.0K | $1.4M | $1.3M | ||||||
| Foreign Currency Transaction Gain Loss Realized | -$485.0K | $414.0K | $395.0K | -$426.0K | -$14.0K | $432.0K | -$454.0K | -$6.0K | -$32.0K | $1.4M | |||||||||||||||||||||||||
| Stock Issued During Period Value Employee Benefit Plan | $595.0K | $632.0K | $294.0K | $3.0M | $283.0K | $128.0K | $204.0K | $146.0K | $168.0K | $168.0K | $773.0K | $63.0K | $608.0K | $55.0K | $60.0K | $46.0K | $32.0K | ||||||||||||||||||
| Stock Issued During Period Value New Issues | $55.9M | $96.9M | $56.6M | $1.6M | $47.0K | $138.0K | $11.4M | $82.8M | $9.1M | ||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $593.0K | $124.0K | $1.8M | $2.4M | $282.0K | $30.0K | $60.0K | $46.0K | $47.0K | $138.0K | $106.0K | $25.0K |
Most recent annual filing with the SEC: July 10, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.